- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05199181
Full Pulpotomy in Mature Teeth With Symptomatic Irreversible Pulpitis as a Routine Treatment in the Primary Care Clinics
January 14, 2022 updated by: Rubén Domínguez Pérez
An Approach Feasibility Study to Establish Full Pulpotomy in Mature Teeth With Symptomatic Irreversible Pulpitis as a Routine Treatment in the Primary Care Dental Clinics of the Public Health System in Mexico
The present study has the objective of being a first approach of the full feasibility study in order to find out whether the Full Pulpotomy performed by a general practice dentist in a primary care dental clinic at the public health system with limited armamentarium could be suitable and present an appropriate success rate as well as patient satisfaction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The present study has the objective of being a first approach of the full feasibility study in order to find out whether the Full Pulpotomy performed by a general practice dentist in a primary care dental clinic at the public health system with limited armamentarium could be suitable and present an appropriate success rate as well as patient satisfaction.
This information will help to decide if a multi-center non-randomized intervention designed study is carried out to determine if it is feasible to provide Full Pulpotomy as a routine treatment to symptomatic irreversible pulpitis or caries pulp exposure at the primary care dental clinics of the public health system in Mexico.
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Querétaro, Mexico, 76138
- Centro de Salud -La Negreta- Jurisdicción Sanitaria 1 del Estado de Querétaro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 100 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
All the patients attending the primary care dental clinic with deep caries and/or pain in a permanent premolar or molar tooth.
- Teeth with complete radicular growth.
- Preoperative symptoms of irreversible pulpitis (Spontaneous pain or exacerbated by thermal stimuli and lasting for a few seconds to several hours interpreted as lingering pain compared with a control tooth and that could be reproduced using thermal testing)
Exclusion Criteria:
Medically comprised or pregnant patients.
- Teeth exclusion criteria:
- Pathological mobility
- Sinus tract
- Teeth that cannot be restored with amalgam
- Radiographic internal or external resorption
- Presence of apical rarefaction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Full pulpotomy
All patients were treated in one visit (with Full Pulpotomy); the previously trained General Practice Dentist performed all the clinical procedures
|
After applying the rubber dam.
Caries, and weak tissues were removed, and the endodontic access was prepared with a carbide bur.
Most of the pulp was removed with a sterile high-speed diamond bur under sterile saline solution irrigation and amputated to the canal orifices level.
Hemostasis was achieved by irrigation of the cavity with the same solution and an application of small cotton pellets for max.10 min.
White Mineral Trioxide Aggregate was mixed according to the manufacturer´s instructions and was placed against the wound after successful hemostasis using an amalgam carrier and packed using an amalgam standard condenser.
The material was adapted and a moistened cotton pellet was placed directly over the Mineral Trioxide Aggregate.
After 15 minutes, the cotton was removed and the tooth was restored with amalgam.
A postoperative radiograph was taken after restoration, general care instructions were given to the patients, and the recommendation of three analgesic intakes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment success rate
Time Frame: 1 Month follow-up
|
To be considered successful, none of the following symptoms had to be present at one month follow-up: persistent pain, exaggerated tenderness to percussion, pathologic mobility, swelling, sinus track related to the treated tooth, evidence of periradicular radiolucency, furcal pathosis, or root resorption
|
1 Month follow-up
|
Treatment success rate
Time Frame: 3 Months follow-up
|
To be considered successful, none of the following symptoms had to be present at three months follow-up: persistent pain, exaggerated tenderness to percussion, pathologic mobility, swelling, sinus track related to the treated tooth, evidence of periradicular radiolucency, furcal pathosis, or root resorption
|
3 Months follow-up
|
Treatment success rate
Time Frame: 6 Months follow-up
|
To be considered successful, none of the following symptoms had to be present at six months follow-up: persistent pain, exaggerated tenderness to percussion, pathologic mobility, swelling, sinus track related to the treated tooth, evidence of periradicular radiolucency, furcal pathosis, or root resorption
|
6 Months follow-up
|
Treatment success rate
Time Frame: 9 Months follow-up
|
To be considered successful, none of the following symptoms had to be present at nine months follow-up: persistent pain, exaggerated tenderness to percussion, pathologic mobility, swelling, sinus track related to the treated tooth, evidence of periradicular radiolucency, furcal pathosis, or root resorption
|
9 Months follow-up
|
Treatment success rate
Time Frame: 12 Months follow-up
|
To be considered successful, none of the following symptoms had to be present at 12 months follow-up: persistent pain, exaggerated tenderness to percussion, pathologic mobility, swelling, sinus track related to the treated tooth, evidence of periradicular radiolucency, furcal pathosis, or root resorption
|
12 Months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction with the effect of the treatment
Time Frame: 24 Hours
|
Patients were contacted by phone to record the satisfaction with the effect of the treatment.
The possible answers for their satisfaction level were: "Very satisfied", "Satisfied", "Neither satisfied nor dissatisfied", "Dissatisfied", or "Very dissatisfied".
|
24 Hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Roberto Sanchez-Lara y Tajonar, DDS, Endod, Universidad Autónoma de Querétaro
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 19, 2019
Primary Completion (Actual)
March 20, 2020
Study Completion (Actual)
March 30, 2021
Study Registration Dates
First Submitted
January 3, 2022
First Submitted That Met QC Criteria
January 14, 2022
First Posted (Actual)
January 20, 2022
Study Record Updates
Last Update Posted (Actual)
January 20, 2022
Last Update Submitted That Met QC Criteria
January 14, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JS1/ENS/215/220
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Symptomatic Irreversible Pulpitis
-
Cairo UniversityNot yet recruitingSymptomatic Irreversible Pulpitis
-
University of California, San FranciscoWithdrawnSymptomatic Irreversible Pulpitis
-
Cairo UniversityUnknown
-
Indiana UniversityRecruitingSymptomatic Irreversible PulpitisUnited States
-
Cairo UniversityNot yet recruitingSymptomatic Irreversible Pulpitis
-
Indiana UniversityCompletedSymptomatic Irreversible PulpitisUnited States
-
Farjad ZafarCompletedSymptomatic Irreversible PulpitisPakistan
-
Cairo UniversityUnknownSymptomatic Irreversible PulpitisEgypt
-
Isfahan University of Medical SciencesCompletedSymptomatic Irreversible PulpitisIran, Islamic Republic of
-
Daniel Chavarría BolañosCompletedSymptomatic Irreversible PulpitisMexico
Clinical Trials on Full pulpotomy
-
Al-Azhar UniversityRecruitingIrreversible PulpitisEgypt
-
Jordan University of Science and TechnologyRecruitingIrreversible Pulpitis | Pulpotomy | Carious Exposure of PulpJordan
-
Nebu PhilipChristian Dental CollegeNot yet recruitingIrreversible PulpitisIndia
-
National University Hospital, SingaporeActive, not recruiting
-
Qatar UniversityCairo University; NYU Langone Health; Mahidol University; Jordan University of... and other collaboratorsRecruitingIrreversible PulpitisQatar
-
Shahid Beheshti University of Medical SciencesCompletedIrreversible PulpitisIran, Islamic Republic of
-
Al-Azhar UniversityCompletedIrreversible Pulpitis | Endodontic InflammationEgypt
-
Charite University, Berlin, Germany3M; SeptodontNot yet recruitingIrreversible Pulpitis | Dentine Caries | Reversible Pulpitis
-
National University Hospital, SingaporeEnrolling by invitationPulpitis - IrreversibleSingapore
-
Ain Shams UniversityNot yet recruiting